BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15203110)

  • 21. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis.
    Dean RA; Butler GS; Hamma-Kourbali Y; Delbé J; Brigstock DR; Courty J; Overall CM
    Mol Cell Biol; 2007 Dec; 27(24):8454-65. PubMed ID: 17908800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells.
    Hamma-Kourbali Y; Bermek O; Bernard-Pierrot I; Karaky R; Martel-Renoir D; Frechault S; Courty J; Delbé J
    BMC Cancer; 2011 May; 11():212. PubMed ID: 21624116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of human thrombomodulin domain as a novel angiogenic factor.
    Shi CS; Shi GY; Chang YS; Han HS; Kuo CH; Liu C; Huang HC; Chang YJ; Chen PS; Wu HL
    Circulation; 2005 Apr; 111(13):1627-36. PubMed ID: 15795324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoassay for measuring the heparin-binding growth factors HARP and MK in biological fluids.
    Soulié P; Héroult M; Bernard I; Kerros ME; Milhiet PE; Delbé J; Barritault D; Caruelle D; Courty J
    J Immunoassay Immunochem; 2002; 23(1):33-48. PubMed ID: 11848100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dominant negative effectors of heparin affin regulatory peptide (HARP) angiogenic and transforming activities.
    Bernard-Pierrot I; Delbé J; Rouet V; Vigny M; Kerros ME; Caruelle D; Raulais D; Barritault D; Courty J; Milhiet PE
    J Biol Chem; 2002 Aug; 277(35):32071-7. PubMed ID: 12070152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
    Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells.
    Bermek O; Diamantopoulou Z; Polykratis A; Dos Santos C; Hamma-Kourbali Y; Burlina F; Delbé J; Chassaing G; Fernig DG; Katsoris P; Courty J
    Exp Cell Res; 2007 Nov; 313(19):4041-50. PubMed ID: 17727841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X-rays affect the expression of genes involved in angiogenesis.
    Polytarchou C; Gligoris T; Kardamakis D; Kotsaki E; Papadimitriou E
    Anticancer Res; 2004; 24(5A):2941-5. PubMed ID: 15517900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage.
    Poon IK; Olsson AK; Hulett MD; Parish CR
    Biochem J; 2009 Oct; 424(1):27-37. PubMed ID: 19712047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
    Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
    Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of HIV-1 Tat peptides for future therapeutic angiogenesis.
    Ismail M; Henklein P; Huang X; Braumann C; Rückert RI; Dubiel W
    Eur J Haematol; 2006 Aug; 77(2):157-65. PubMed ID: 16800839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch.
    Zhang N; Zhong R; Perez-Pinera P; Herradon G; Ezquerra L; Wang ZY; Deuel TF
    Biochem Biophys Res Commun; 2006 May; 343(2):653-8. PubMed ID: 16554021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide.
    Laaroubi K; Delbé J; Vacherot F; Desgranges P; Tardieu M; Jaye M; Barritault D; Courty J
    Growth Factors; 1994; 10(2):89-98. PubMed ID: 7520717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins.
    Tammela T; He Y; Lyytikkä J; Jeltsch M; Markkanen J; Pajusola K; Ylä-Herttuala S; Alitalo K
    Circ Res; 2007 May; 100(10):1468-75. PubMed ID: 17478733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin affin regulatory peptide in milk: its involvement in mammary gland homeostasis.
    Bernard-Pierrot I; Delbé J; Heroult M; Rosty C; Soulié P; Barritault D; Milhiet PE; Courty J
    Biochem Biophys Res Commun; 2004 Jan; 314(1):277-82. PubMed ID: 14715276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycosaminoglycan-dependent and -independent inhibition of neurite outgrowth by agrin.
    Baerwald-de la Torre K; Winzen U; Halfter W; Bixby JL
    J Neurochem; 2004 Jul; 90(1):50-61. PubMed ID: 15198666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin mimetic peptide nanofibers promote angiogenesis.
    Mammadov R; Mammadov B; Toksoz S; Aydin B; Yagci R; Tekinay AB; Guler MO
    Biomacromolecules; 2011 Oct; 12(10):3508-19. PubMed ID: 21853983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44.
    Hibino S; Shibuya M; Hoffman MP; Engbring JA; Hossain R; Mochizuki M; Kudoh S; Nomizu M; Kleinman HK
    Cancer Res; 2005 Nov; 65(22):10494-501. PubMed ID: 16288042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.